{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:23:54Z","timestamp":1779110634629,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,18]]},"DOI":"10.7759\/cureus.47267","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:20:04Z","timestamp":1697642404000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of Refractory Diffuse Alveolar Hemorrhage as a Complication of Antiphospholipid Syndrome and Review of Its Management"],"prefix":"10.7759","author":[{"given":"Denis","family":"Ruzdija","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Bertolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaunak K","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Amaraneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim W","year":"2013","unstructured":"Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013, 2013:675-80. 10.1182\/asheducation-2013.1.675","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01906-1","article-title":"Reducing the diagnostic delay in antiphospholipid syndrome over time: a real world observation","volume":"16","author":"Radin M","year":"2021","unstructured":"Radin M, Foddai SG, Barinotti A, Cecchi I, Rubini E, Sciascia S, Roccatello D. Reducing the diagnostic delay in antiphospholipid syndrome over time: a real world observation. Orphanet J Rare Dis. 2021, 16:280. 10.1186\/s13023-021-01906-1","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia D","year":"2018","unstructured":"Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018, 378:2010-21. 10.1056\/NEJMra1705454","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-013-0056-5","article-title":"Treatment of the antiphospholipid syndrome","volume":"5","author":"Galli M","year":"2014","unstructured":"Galli M. Treatment of the antiphospholipid syndrome. Auto Immun Highlights. 2014, 5:1-7. 10.1007\/s13317-013-0056-5","journal-title":"Auto Immun Highlights"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa G","year":"2002","unstructured":"Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002, 61:195-8. 10.1136\/ard.61.3.195","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara AR","year":"2010","unstructured":"Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010, 137:1164-71. 10.1378\/chest.08-2084","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2014.01.002","article-title":"Diffuse pulmonary hemorrhage: clues to the diagnosis","volume":"43","author":"Lichtenberger JP 3rd","year":"2014","unstructured":"Lichtenberger JP 3rd, Digumarthy SR, Abbott GF, Shepard JA, Sharma A. Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol. 2014, 43:128-39. 10.1067\/j.cpradiol.2014.01.002","journal-title":"Curr Probl Diagn Radiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.20.23399","article-title":"A review of clinical and imaging features of diffuse pulmonary hemorrhage","volume":"216","author":"Reisman S","year":"2021","unstructured":"Reisman S, Chung M, Bernheim A. A review of clinical and imaging features of diffuse pulmonary hemorrhage. AJR Am J Roentgenol. 2021, 216:1500-9. 10.2214\/AJR.20.23399","journal-title":"AJR Am J Roentgenol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0852-7","article-title":"Clinical insights into diffuse alveolar hemorrhage in antiphospholipid syndrome","volume":"21","author":"Stoots SA","year":"2019","unstructured":"Stoots SA, Lief L, Erkan D. Clinical insights into diffuse alveolar hemorrhage in antiphospholipid syndrome. Curr Rheumatol Rep. 2019, 21:56. 10.1007\/s11926-019-0852-7","journal-title":"Curr Rheumatol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020793","article-title":"Treatment of diffuse alveolar hemorrhage: controlling inflammation and obtaining rapid and effective hemostasis","volume":"22","author":"Park JA","year":"2021","unstructured":"Park JA. Treatment of diffuse alveolar hemorrhage: controlling inflammation and obtaining rapid and effective hemostasis. Int J Mol Sci. 2021, 22:793. 10.3390\/ijms22020793","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0074-5","article-title":"Use of rituximab in the antiphospholipid syndrome","volume":"12","author":"Kumar D","year":"2010","unstructured":"Kumar D, Roubey RA. Use of rituximab in the antiphospholipid syndrome. Curr Rheumatol Rep. 2010, 12:40-4. 10.1007\/s11926-009-0074-5","journal-title":"Curr Rheumatol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078402","article-title":"B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres","volume":"67","author":"Ioannou Y","year":"2008","unstructured":"Ioannou Y, Lambrianides A, Cambridge G, Leandro MJ, Edwards JC, Isenberg DA. B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres. Ann Rheum Dis. 2008, 67:425-6. 10.1136\/ard.2007.078402","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi A","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009, 6:638-47. 10.1038\/nrclinonc.2009.146","journal-title":"Nat Rev Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.11.009","article-title":"Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature","volume":"15","author":"Tenti S","year":"2016","unstructured":"Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A. Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature. Autoimmun Rev. 2016, 15:226-35. 10.1016\/j.autrev.2015.11.009","journal-title":"Autoimmun Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12363","article-title":"Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients","volume":"11","author":"Schmidt-Tanguy A","year":"2013","unstructured":"Schmidt-Tanguy A, Voswinkel J, Henrion D, et al.. Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost. 2013, 11:1927-9. 10.1111\/jth.12363","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000073","article-title":"Is there a role for immunosuppression in antiphospholipid syndrome?","volume":"2019","author":"Sevim E","year":"2019","unstructured":"Sevim E, Willis R, Erkan D. Is there a role for immunosuppression in antiphospholipid syndrome?. Hematology Am Soc Hematol Educ Program. 2019, 2019:426-32. 10.1182\/hematology.2019000073","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mTORC pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud G","year":"2014","unstructured":"Canaud G, Bienaim\u00e9 F, Tabarin F, et al.. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014, 371:303-12. 10.1056\/NEJMoa1312890","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00969","article-title":"Cellular and molecular mechanisms of anti-phospholipid syndrome","volume":"9","author":"Radic M","year":"2018","unstructured":"Radic M, Pattanaik D. Cellular and molecular mechanisms of anti-phospholipid syndrome. Front Immunol. 2018, 9:969. 10.3389\/fimmu.2018.00969","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171373-a-case-report-of-refractory-diffuse-alveolar-hemorrhage-as-a-complication-of-antiphospholipid-syndrome-and-review-of-its-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:10Z","timestamp":1707509470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171373-a-case-report-of-refractory-diffuse-alveolar-hemorrhage-as-a-complication-of-antiphospholipid-syndrome-and-review-of-its-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.47267","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,18]]}}}